Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2022 08:25 ET | Source: Exagen Inc.

Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems

SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests have entered into an in-network...
March 22, 2022 16:06 ET | Source: Exagen Inc.

Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® tests will soon surpass 90 million lives as...
March 22, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
March 16, 2022 16:05 ET | Source: Exagen Inc.

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the formation of its new Scientific Advisory Board (SAB)...
March 09, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life...
March 08, 2022 16:05 ET | Source: Exagen Inc.

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December...
January 30, 2020 06:55 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Announces Addition to Board of Directors and Changes in Leadership

Ron Rocca, CEO of Exagen, appointed to BoardJames Early, CFO announces retirement; Fred Knechtel, formerly CFO of GENEWIZ, appointed as CFOJeff Salzman, formerly of CareDX, appointed VP of Managed...